Recombinant Rhesus Macaque SLC2A1 Protein, His (Fc)-Avi-tagged
Cat.No. : | SLC2A1-4079R |
Product Overview : | Recombinant Rhesus Macaque SLC2A1 with His (Fc)-Avi tag was expressed and purified |
- Specification
- Gene Information
- Related Products
- Download
Source : | HEK293 |
Species : | Rhesus Macaque |
Tag : | His&Fc&Avi |
Endotoxin : | < 1.0 EU per μg of the protein as determined by the LAL method |
Purity : | ≥85% by SDS-PAGE |
Stability : | Stable for at least 6 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Storage : | For long term storage, aliquot and store at -20 to -80 centigrade. Avoid repeated freezing and thawing cycles. |
Storage Buffer : | PBS buffer |
Gene Name : | SLC2A1 solute carrier family 2 (facilitated glucose transporter), member 1 [ Macaca mulatta (Rhesus monkey) ] |
Official Symbol : | SLC2A1 |
Synonyms : | SLC2A1; solute carrier family 2, facilitated glucose transporter member 1; |
Gene ID : | 698931 |
mRNA Refseq : | NM_001257862 |
Protein Refseq : | NP_001244791 |
UniProt ID : | F6YFI2 |
Products Types
◆ Recombinant Protein | ||
Slc2a1-4110R | Recombinant Rat Slc2a1 protein(207-271aa), His&Myc-tagged | +Inquiry |
Slc2a1-1232R | Recombinant Rat Slc2a1 Protein, His&SUMO-tagged | +Inquiry |
SLC2A1-8310M | Recombinant Mouse SLC2A1 Protein, His (Fc)-Avi-tagged | +Inquiry |
Slc2a1-5919M | Recombinant Mouse Slc2a1 Protein, Myc/DDK-tagged | +Inquiry |
SLC2A1-059H | Recombinant Human SLC2A1 Protein, MYC/DDK-tagged, C13 and N15-labeled | +Inquiry |
Related Gene
Not For Human Consumption!
Inquiry
- Reviews
- Q&As
Customer Reviews (3)
Write a reviewQuality product, great results.
Fast and efficient service.
Excellent for immunofluorescence.
Q&As (7)
Ask a questionSLC2A1 facilitates the passive transport of glucose across cell membranes, especially in conditions of low glucose concentration.
Besides glucose, SLC2A1 can also transport other hexoses such as galactose.
SLC2A1 expression is upregulated in response to low glucose availability to ensure sufficient glucose uptake.
Therapeutic interventions could involve managing glucose levels and ketogenic diets to bypass the glucose transport defect in conditions like GLUT1 deficiency syndrome.
It is ubiquitously expressed but is particularly prevalent in erythrocytes and the endothelial cells of the blood-brain barrier.
Mutations or dysregulations in SLC2A1 can lead to glucose transport deficiencies, affecting energy supply to cells.
Mutations in SLC2A1 are associated with GLUT1 deficiency syndrome, which can result in epilepsy, developmental delay, and movement disorders.
Ask a Question for All SLC2A1 Products
Required fields are marked with *
My Review for All SLC2A1 Products
Required fields are marked with *
Inquiry Basket